Related Experiment Video
Updated: Aug 25, 2026

Determination of the Optimal Chromosomal Location(s) for a DNA Element in Escherichia coli Using a Novel Transposon-mediated Approach
Published on: September 11, 2017
Cloning and characterization of the 5'-flanking sequence for the human DNA topoisomerase II beta gene
1Hematology/Oncology Division, Harvard Institutes of Medicine, Beth Israel Deaconess Medical Centre, East Campus, Boston, MA 02215, USA.
Abstract:
Mammalian cells express two isoforms of type II DNA topoisomerase which are the intracellular targets of many structurally diverse antineoplastic agents. The levels of topoisomerase II isozymes are important determinants for the sensitivity of cells to the cytotoxicity of drugs that target topoisomerase II. To investigate whether the expression of topoisomerase II isoforms is coordinated and the mechanisms governing their expression in the context of drug resistance, the 5'-flanking sequence for the gene of human topoisomerase IIbeta isoform was cloned and characterized. The 5'-flanking region has a very high GC content and contains no canonical TATA box element. Two separate transcriptional start sites are located to an adenine and a guanine, 193 and 89 nucleotides, respectively, upstream from the ATG translation initiation codon. Except for a small region immediately upstream of the translation initiation codon, there is no obvious sequence homology between the 5'-flanking sequences of human topoisomerase IIbeta gene and the previously described alpha gene. Transient expression assays with different 5'- and 3'-deletions of the 5'-flanking region of the topoisomerase IIbeta gene have delineated regions important for transcriptional regulation of the gene. Interestingly, sequences within the first intron also contribute to the promoter activity. Gel mobility shift studies demonstrate that protein factors from the nuclear extracts can bind specifically to the downstream elements and may participate in transcriptional regulation.
Insights
Investigating human topoisomerase IIbeta gene expression, this study identified key regulatory regions in its 5'-flanking sequence. These findings are crucial for understanding drug resistance mechanisms in cancer therapy.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Mammalian cells possess two type II DNA topoisomerase isoforms, critical targets for numerous anticancer drugs.
- Cellular sensitivity to topoisomerase II-targeting drugs is significantly influenced by the expression levels of these isozymes.
Purpose of the Study:
- To explore the coordinated expression of topoisomerase II isoforms.
- To elucidate the regulatory mechanisms governing gene expression in the context of drug resistance.
- To clone and characterize the 5"-flanking sequence of the human topoisomerase IIbeta gene.
Main Methods:
- Cloning and characterization of the 5"-flanking sequence of the human topoisomerase IIbeta gene.
- Analysis of transcriptional start sites and GC content.
- Transient expression assays with 5"- and 3"-deletions.
- Gel mobility shift studies to identify protein-DNA interactions.
Main Results:
- The 5"-flanking region of the topoisomerase IIbeta gene exhibits high GC content and lacks a TATA box, with two distinct transcriptional start sites.
- Limited sequence homology exists between the 5"-flanking regions of topoisomerase IIbeta and topoisomerase IIalpha genes.
- Deletion analyses identified critical regions for transcriptional regulation, including sequences within the first intron that enhance promoter activity.
- Nuclear protein factors specifically bind to downstream elements, suggesting a role in transcriptional regulation.
Conclusions:
- The study delineates regulatory elements controlling human topoisomerase IIbeta gene expression.
- Understanding these mechanisms is vital for developing strategies to overcome drug resistance in cancer treatment.
- The findings contribute to the broader understanding of topoisomerase II gene regulation and its implications in oncology.
Related Concept Videos
DNA Helicases
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Telomeres and Telomerase
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Inhibitors of Bacterial DNA Synthesis

